# Orsobio

> Analysis by Optimly for Optimly AI Visibility, in the Optimly AI Brand Index. Last analyzed September 14, 2026.

> OrsoBio is a biotechnology company focused on developing novel oral therapeutics for severe metabolic disorders, including severe hypertriglyceridemia (SHTG), metabolic dysfunction–associated steatotic liver disease (MASLD)/MASH, and obesity. The company is advancing drugs like TLC-2716 and TLC-6740 through clinical trials.

- Business Profile: https://optimly.ai/brand/orsobio
- Publisher: Optimly (https://optimly.ai)
- Dataset: Optimly AI Brand Index (https://optimly.ai/brand)
- Official website: https://fiercebiotech.com/
- Logo: https://logo.clearbit.com/fiercebiotech.com
- Slug: orsobio
- Brand Authority Index tier: Low Visibility
- Category: Pharmaceutical Companies
- Last Analyzed: September 14, 2026
---
## Full Details / RAG Data
### Overview
Orsobio has a Business Profile in the Optimly AI Brand Index.
OrsoBio is a biotechnology company focused on developing novel oral therapeutics for severe metabolic disorders, including severe hypertriglyceridemia (SHTG), metabolic dysfunction–associated steatotic liver disease (MASLD)/MASH, and obesity. The company is advancing drugs like TLC-2716 and TLC-6740 through clinical trials.
### Metadata
| Field        | Value |
|--------------|-------|
| Name         | Orsobio |
| Slug         | orsobio |
| URL          | https://optimly.ai/brand/orsobio |
| Logo         | https://logo.clearbit.com/fiercebiotech.com |
| Brand Authority Index tier | Low Visibility |
| Category     | Pharmaceutical Companies |
| Last Analyzed | September 14, 2026 |
| Last Updated | 2026-09-22T03:34:30.590Z |
### Links
- Canonical page: https://optimly.ai/brand/orsobio
- Official website: https://fiercebiotech.com/
- Publisher: https://optimly.ai
- Dataset: https://optimly.ai/brand
- JSON endpoint: /brand/orsobio.json
- LLMs.txt: /brand/orsobio/llms.txt